Impact of early tumor response on prognostic of patients with unresectable liver metastases from wt-KRAS colorectal cancer (LM-CRC) treated with hepatic artery infusion of irinotecan, 5-fluorouracil and oxaliplatin plus intravenous cetuximab after failure of systemic chemotherapy (European Phase II OPTILIV).
作者： Mohamed Bouchahda , Valerie Boige , Denis Michel Smith , Abdoulaye Karaboué , Mohamed Hebbar
DOI: 10.1200/JCO.2016.34.15_SUPPL.E15036
关键词: Cetuximab 、 Internal medicine 、 Irinotecan 、 KRAS 、 Oxaliplatin 、 Medicine 、 Fluorouracil 、 Chemotherapy 、 Colorectal cancer 、 Tumor response 、 Oncology
摘要: e15036Background: Early tumor shrinkage has been associated with improved long-term outcome in patients (pts) chemotherapy (chemo)-refractory LM-CRC. We examined the prognostic relevance of ea...
sci-hub.st 参考文章(0)